Reported covered position: Member, US House of Representatives 1980-1994
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2022 · first_quarter · Q1
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2021 · fourth_quarter · Q4
Source: Senate LDA
| Amarin Pharma, Inc. |
| 6 |
| 2019–2020 |
| KANEKA PHARMA AMERICA, LLC | 6 | 2019–2020 |
| RAC COALITION (INFORMAL COALITION) | 6 | 2013–2015 |
| MUSCULAR DYSTROPHY ASSOCIATION, INC. | 4 | 2014–2016 |
| PARTNERSHIP FOR QUALITY HOME HEALTHCARE | 4 | 2013–2014 |
| PATHCON LABORATORIES | 4 | 2014 |
| ZEKELMAN INDUSTRIES (FORMERLY KNOWN AS JMC STEEL GROUP) | 4 | 2014 |
| ADVENTIST HEALTHCARE | 3 | 2018 |
| AUDENTES THERAPEUTICS | 3 | 2019–2020 |
| CONCEIVEX, INC. | 3 | 2016 |
| FORT BEND COUNTY, TEXAS | 3 | 2021 |
| OMEROS CORPORATION | 2 | 2017–2018 |
| BANKER STEEL COMPANY | 1 | 2018 |
| STARK REFORM COALITION (INFORMAL COALITION) | 1 | 2016 |
| THE BRINK'S COMPANY | 1 | 2015 |
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2020
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S. 4259/H.R. 7757); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2020
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S. 4259/H.R. 7757); access to CARES Act Provider Relief Fund
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Long-Term Care Pharmacy Definition Act of 2020
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.4259/H.R. 7757); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2020
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.4259/H.R. 7757); access to CARES Act Provider Relief Fund
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Long-Term Care Pharmacy Definition Act of 2020
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.4259/H.R. 7757); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2020
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.4259/H.R. 7757); access to CARES Act Provider Relief Fund
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Advocacy for PAID Act, H.R. 1375 and other Medicare Secondary Payer issues
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Defending American Security from Kremlin Aggression Act of 2019
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Defending American Security from Kremlin Aggression Act of 2019
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Defending American Security from Kremlin Aggression Act of 2019
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Defending American Security from Kremlin Aggression Act of 2019
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
-- H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act -- Medicaid Third Party Liability and Extension of MACRA Section 220 -- Advocate for PAID Act
-- H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act -- Medicaid Third Party Liability and Extension of MACRA Section 220 -- Advocate for H.R. 5881, PAID Act
-- Advocate for H.R. 5881, PAID Act
-- Advocate for H.R. 5881, PAID Act
-- H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act -- Medicaid Third Party Liability and Extension of MACRA Section 220 -- Advocate for H.R. 5881, PAID Act
Defending American Security from Kremlin Aggression Act of 2018
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
Steel and pipe issues; Issues related to S. 3336, Defending American Security from Kremlin Aggression Act of 2018
Russia Sanctions Review Act of 2017
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017.
Russia Sanctions Review Act of 2017
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017; S.722: Countering Iran's Destabilizing Activities Act of 2017, Title II - Sanctions with Respect to the Russian Federation and Combating Terrorism and Illicit Financing
Russia Sanctions Review Act of 2017
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017; S.722: Countering Iran's Destabilizing Activities Act of 2017, Title II - Sanctions with Respect to the Russian Federation and Combating Terrorism and Illicit Financing
H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act
H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act
H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act
-- H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act -- Medicaid Third Party Liability and Extension of MACRA Section 220
Russia Sanctions Review Act of 2017
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017; S.722: Countering Iran's Destabilizing Activities Act of 2017, Title II - Sanctions with Respect to the Russian Federation and Combating Terrorism and Illicit Financing
Russia Sanctions Review Act of 2017
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017.
Russia Sanctions Review Act of 2017
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017; S.722: Countering Iran's Destabilizing Activities Act of 2017, Title II - Sanctions with Respect to the Russian Federation and Combating Terrorism and Illicit Financing
Countering Iran's Destabilizing Activities Act of 2017
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017; S.722: Countering Iran's Destabilizing Activities Act of 2017, Title II - Sanctions with Respect to the Russian Federation and Combating Terrorism and Illicit Financing
Countering Iran's Destabilizing Activities Act of 2017
Client: IPSCO TUBULARS, INC. (DBA TMK IPSCO) · Firm: KING & SPALDING LLP
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017; S.722: Countering Iran's Destabilizing Activities Act of 2017, Title II - Sanctions with Respect to the Russian Federation and Combating Terrorism and Illicit Financing
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and increased funding for the NIH. H.R. 6, 21st Century Cures, and Innovation for Healthier Americans initiative.
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Strengthening Medicare And Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Strengthening Medicare And Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Strengthening Medicare And Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Strengthening Medicare And Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Protecting the Integrity of Medicare Act of 2015
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 and H.R. 1021, Protecting the Integrity of Medicare Act of 2015
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of HR 1178, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015
Client: MUSCULAR DYSTROPHY ASSOCIATION INC · Firm: KING & SPALDING LLP
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and increased funding for the NIH. H.R. 209/S. 139, Expanding Access to Clinical Trials Act of 2015 H.R. 6, 21st Century Cures and Innovation for Healthier Americans initiatives H.R. 1516/S. 1013, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015
Medicare Access and CHIP Reauthorization Act of 2015
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 and H.R. 1021, Protecting the Integrity of Medicare Act of 2015
Ensuring Access to Clinical Trials Act of 2015
Client: MUSCULAR DYSTROPHY ASSOCIATION INC · Firm: KING & SPALDING LLP
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and increased funding for the NIH. H.R. 209/S. 139, Expanding Access to Clinical Trials Act of 2015 H.R. 6, 21st Century Cures and Innovation for Healthier Americans initiatives H.R. 1516/S. 1013, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and increased funding for the NIH. H.R. 209/S. 139, Expanding Access to Clinical Trials Act of 2015 H.R. 6, 21st Century Cures and Innovation for Healthier Americans initiatives H.R. 1516/S. 1013, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015
Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015
Client: MUSCULAR DYSTROPHY ASSOCIATION INC · Firm: KING & SPALDING LLP
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and increased funding for the NIH. H.R. 209/S. 139, Expanding Access to Clinical Trials Act of 2015 H.R. 6, 21st Century Cures and Innovation for Healthier Americans initiatives H.R. 1516/S. 1013, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015
Ensuring Access to Clinical Trials Act of 2015
Client: MUSCULAR DYSTROPHY ASSOCIATION INC · Firm: KING & SPALDING LLP
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and increased funding for the NIH. H.R. 209/S. 139, Expanding Access to Clinical Trials Act of 2015 H.R. 6, 21st Century Cures and Innovation for Healthier Americans initiatives H.R. 1516/S. 1013, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Ensuring Equal Access to Treatments Act of 2015
Client: PHOTOCURE, INC. · Firm: KING & SPALDING LLP
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Strengthening Medicare And Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Strengthening Medicare And Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation, including H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015
Strengthening Medicare And Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Strengthening Medicare And Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation.
Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation, including H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015
Repealing the Job-Killing Health Care Law Act
Client: MARC COALITION · Firm: KING & SPALDING LLP
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation, including H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015
Medicare Audit Improvement Act of 2013
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013; and draft legislation, Protecting Integrity in Medicare Act of 2014 (PIMA); Hospitals Improvement for Payment (HIP) Act of 2014; and H.R. 83 - Consolidated and Further Continuing Appropriations Act, 2015 (Public Law 113-235)
Medicare Audit Improvement Act of 2013
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013; and H.R. 4302, the Protecting Access to Medicare Act (Public Law No: 113-93).
Medicare Audit Improvement Act of 2013
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; and S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013.
Newborn Screening Saves Lives Reauthorization Act of 2014
Client: MUSCULAR DYSTROPHY ASSOCIATION INC · Firm: KING & SPALDING LLP
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues. H.R. 594/S. 315, the Paul D. Wellstone Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2013 H.R. 1281/S. 1417, the Newborn Screening Saves Lives Reauthorization Act of 2013
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013; and draft legislation, Protecting Integrity in Medicare Act of 2014 (PIMA); Hospitals Improvement for Payment (HIP) Act of 2014; and H.R. 83 - Consolidated and Further Continuing Appropriations Act, 2015 (Public Law 113-235)
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; and S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013.
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013; and H.R. 4302, the Protecting Access to Medicare Act (Public Law No: 113-93).
Administrative Relief and Accurate Medicare Payments Act of 2013
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013; and draft legislation, Protecting Integrity in Medicare Act of 2014 (PIMA); Hospitals Improvement for Payment (HIP) Act of 2014; and H.R. 83 - Consolidated and Further Continuing Appropriations Act, 2015 (Public Law 113-235)
Administrative Relief and Accurate Medicare Payments Act of 2013
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; and S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013.
Administrative Relief and Accurate Medicare Payments Act of 2013
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013; and H.R. 4302, the Protecting Access to Medicare Act (Public Law No: 113-93).
Protecting Access to Medicare Act of 2014
Client: RAC COALITION (INFORMAL COALITION) · Firm: KING & SPALDING LLP
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 1250/S. 1012, Medicare Audit Improvement Act of 2013; H.R. 2305/S. 1123 - Preventing and Reducing Improper Medicare and Medicaid Expenditures Act of 2013; H.R. 2329 - Administrative Relief and Accurate Medicare Payments Act of 2013; S.1871, the SGR Repeal and Medicare Beneficiary Access Act of 2013; and H.R. 4302, the Protecting Access to Medicare Act (Public Law No: 113-93).
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2021 · third_quarter · Q3
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FORT BEND COUNTY, TEXAS via KING & SPALDING LLP
2021 · second_quarter · Q2
Advocacy related to flood and drainage control; The American Jobs Plan
Advocacy related to funding road replacement; Advocacy related to drainage funding; The American Jobs Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2021 · second_quarter · Q2
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FORT BEND COUNTY, TEXAS via KING & SPALDING LLP
2021 · first_quarter · Q1
Advocacy related to flood and drainage control; The American Jobs Plan
Advocacy related to drainage funding; The American Jobs Plan
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2021 · first_quarter · Q1
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S. 4259/H.R. 7757); access to CARES Act Provider Relief Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FORT BEND COUNTY, TEXAS via KING & SPALDING LLP
2021 · first_quarter · RR
Advocacy related to funding for transportation projects, flood mitigation and other emergency response, and COVID-19 emergency.
Advocacy related to funding for transportation projects, flood mitigation and other emergency response, and COVID-19 emergency.
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2020 · fourth_quarter · Q4
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.4259/H.R. 7757); access to CARES Act Provider Relief Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2020 · third_quarter · Q3
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.4259/H.R. 7757); access to CARES Act Provider Relief Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2020 · second_quarter · Q2
Part D coverage of long term care pharmacy and definition of long term care pharmacy; access to CARES Act Provider Relief Fund
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2020 · first_quarter · Q1
Part D coverage of long term care pharmacy and definition of long term care pharmacy
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
MARC COALITION via KING & SPALDING LLP
2020 · first_quarter · Q1
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2020 · first_quarter · Q1
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AUDENTES THERAPEUTICS via KING & SPALDING LLP
2020 · first_quarter · Q1
Advocacy related to value-based payments for regenerative medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMARIN PHARMA, INC. via KING & SPALDING LLP
2020 · first_quarter · Q1
Advocacy related to cardiovascular health and reduction of residual risk after statins
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2019 · fourth_quarter · Q4
Part D coverage of long term care pharmacy and definition of long term care pharmacy
Filing targets: Centers For Medicare and Medicaid Services (CMS), SENATE
MARC COALITION via KING & SPALDING LLP
2019 · fourth_quarter · Q4
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2019 · fourth_quarter · Q4
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMARIN PHARMA, INC. via KING & SPALDING LLP
2019 · fourth_quarter · Q4
Advocacy related to cardiovascular health and reduction of residual risk after statins
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2019 · fourth_quarter · Q4
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AUDENTES THERAPEUTICS via KING & SPALDING LLP
2019 · fourth_quarter · Q4
Advocacy related to value-based payments for regenerative medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2019 · third_quarter · Q3
Part D coverage of long term care pharmacy and definition of long term care pharmacy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), SENATE
MARC COALITION via KING & SPALDING LLP
2019 · third_quarter · Q3
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2019 · third_quarter · Q3
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AUDENTES THERAPEUTICS via KING & SPALDING LLP
2019 · third_quarter · Q3
Advocacy related to value-based payments for regenerative medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMARIN PHARMA, INC. via KING & SPALDING LLP
2019 · third_quarter · Q3
Advocacy related to cardiovascular health and reduction of residual risk after statins
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2019 · third_quarter · Q3
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2019 · second_quarter · 2A
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Treasury, Dept of
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2019 · second_quarter · 2A
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMARIN PHARMA, INC. via KING & SPALDING LLP
2019 · second_quarter · 2A
Advocacy related to cardiovascular health and reduction of residual risk after statins
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2019 · second_quarter · Q2
Part D coverage of long term care pharmacy and definition of long term care pharmacy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), SENATE
MARC COALITION via KING & SPALDING LLP
2019 · second_quarter · Q2
Advocacy for PAID Act, H.R. 1375, S. 1918 and other Medicare Secondary Payer issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Treasury, Dept of
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2019 · second_quarter · Q2
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMARIN PHARMA, INC. via KING & SPALDING LLP
2019 · second_quarter · Q2
Advocacy related to cardiovascular health and reduction of residual risk after statins
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2019 · second_quarter · Q2
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2019 · first_quarter · Q1
Part D coverage of long term care pharmacy and definition of long term care pharmacy
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2019 · first_quarter · Q1
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
MARC COALITION via KING & SPALDING LLP
2019 · first_quarter · Q1
Advocacy for PAID Act, H.R. 1375 and other Medicare Secondary Payer issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Treasury, Dept of
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2019 · first_quarter · Q1
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMARIN PHARMA, INC. via KING & SPALDING LLP
2019 · first_quarter · Q1
Advocacy related to cardiovascular health and reduction of residual risk after statins
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2019 · first_quarter · Q1
Steel and pipe issues; Russia sanctions issues; Issues related to Countering America's Adversaries Through Sanctions Act (CAATSA) (PL 115-44); Defending Elections against Trolls from Enemy Regimes Act or DETER Act (S. 2785); and Defending American Security from Kremlin Aggression Act (DASKA) (S. 482)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2018 · fourth_quarter · Q4
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
MARC COALITION via KING & SPALDING LLP
2018 · fourth_quarter · Q4
-- Advocate for H.R. 5881, PAID Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Treasury, Dept of
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2018 · fourth_quarter · Q4
Steel and pipe issues; Russia sanctions issues, Issues related to Countering Americas Adversaries Through Sanctions Act (CAATSA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
PHOTOCURE, INC. via KING & SPALDING LLP
2018 · third_quarter · Q3
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2018 · third_quarter · Q3
-- Advocate for H.R. 5881, PAID Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2018 · third_quarter · Q3
-- Advocacy on children's mental health issues -- Authorize funding for CURES 10006 program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2018 · third_quarter · Q3
Steel and pipe issues; Issues related to S. 3336, Defending American Security from Kremlin Aggression Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2018 · second_quarter · Q2
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2018 · second_quarter · Q2
-- H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act -- Medicaid Third Party Liability and Extension of MACRA Section 220 -- Advocate for H.R. 5881, PAID Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2018 · second_quarter · Q2
-- Advocacy on children's mental health issues -- Authorize funding for CURES 10006 program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2018 · second_quarter · Q2
Steel and pipe issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2018 · first_quarter · Q1
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2018 · first_quarter · Q1
-- H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act -- Medicaid Third Party Liability and Extension of MACRA Section 220 -- Advocate for PAID Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2018 · first_quarter · Q1
-- Advocacy on children's mental health issues -- Authorize funding for CURES 10006 program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OMEROS CORPORATION via KING & SPALDING LLP
2018 · first_quarter · Q1
Reimbursement of outpatient medications
Filing targets: HOUSE OF REPRESENTATIVES
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2018 · first_quarter · Q1
Steel and pipe issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANKER STEEL COMPANY via KING & SPALDING LLP
2018 · first_quarter · RR
NAFTA negotiations, Section 232 tariffs, and related steel issues
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2017 · fourth_quarter · Q4
Steel and pipe issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2017 · fourth_quarter · Q4
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
OMEROS CORPORATION via KING & SPALDING LLP
2017 · fourth_quarter · Q4
Reimbursement of outpatient medications
Filing targets: HOUSE OF REPRESENTATIVES
MARC COALITION via KING & SPALDING LLP
2017 · fourth_quarter · Q4
-- H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act -- Medicaid Third Party Liability and Extension of MACRA Section 220
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALERE, INC. via KING & SPALDING LLP
2017 · fourth_quarter · Q4
Medicare enrollment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2017 · third_quarter · Q3
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017; S.722: Countering Iran's Destabilizing Activities Act of 2017, Title II - Sanctions with Respect to the Russian Federation and Combating Terrorism and Illicit Financing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2017 · third_quarter · Q3
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2017 · third_quarter · Q3
H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALERE, INC. via KING & SPALDING LLP
2017 · third_quarter · Q3
Medicare enrollment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2017 · second_quarter · Q2
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017; S.722: Countering Iran's Destabilizing Activities Act of 2017, Title II - Sanctions with Respect to the Russian Federation and Combating Terrorism and Illicit Financing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALERE, INC. via KING & SPALDING LLP
2017 · second_quarter · Q2
Medicare enrollment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2017 · second_quarter · Q2
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2017 · second_quarter · Q2
H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IPSCO TUBULARS, INC. (DBA TMK IPSCO) via KING & SPALDING LLP
2017 · second_quarter · RR
H.R. 1059 / S. 341: Russian Sanctions Review Act of 2017.
ALERE, INC. via KING & SPALDING LLP
2017 · first_quarter · Q1
Medicare enrollment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2017 · first_quarter · Q1
Advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2017 · first_quarter · Q1
H.R. 1122, the Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION INC via KING & SPALDING LLP
2016 · fourth_quarter · Q4
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues.
Filing targets: SENATE
ALERE, INC. via KING & SPALDING LLP
2016 · fourth_quarter · Q4
Medicare enrollment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2016 · fourth_quarter · Q4
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2016 · fourth_quarter · Q4
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALERE, INC. via KING & SPALDING LLP
2016 · fourth_quarter · RR
Medicare enrollment
CONCEIVEX, INC. via KING & SPALDING LLP
2016 · third_quarter · Q3
Coverage for fertility treatments by the VA and DoD
Coverage for fertility treatments by the VA and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2016 · third_quarter · Q3
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2016 · third_quarter · Q3
Medicare Secondary Payer issues, including H.R. 6120, H.R. 1063, S. 1718, and H.R. 1845 (112th Congress) implementation; advocacy related to H.R. 6120, SPARC Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONCEIVEX, INC. via KING & SPALDING LLP
2016 · second_quarter · Q2
Coverage for fertility treatments by the VA and DoD
Coverage for fertility treatments by the VA and DoD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION INC via KING & SPALDING LLP
2016 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and increased funding for the NIH. H.R. 6, 21st Century Cures, and Innovation for Healthier Americans initiative.
Filing targets: SENATE
STARK REFORM COALITION (INFORMAL COALITION) via KING & SPALDING LLP
2016 · second_quarter · Q2
Common sense reform of the Stark law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONCEIVEX, INC. via KING & SPALDING LLP
2016 · second_quarter · RR
Coverage for fertility treatments by the VA and DoD
Coverage for fertility treatments by the VA and DoD
PHOTOCURE, INC. via KING & SPALDING LLP
2016 · second_quarter · Q2
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2016 · second_quarter · Q2
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2016 · first_quarter · Q1
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2016 · first_quarter · Q1
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2015 · fourth_quarter · Q4
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2015 · fourth_quarter · Q4
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2015 · third_quarter · Q3
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUSCULAR DYSTROPHY ASSOCIATION INC via KING & SPALDING LLP
2015 · second_quarter · Q2
Health care issues affecting individuals with neuromuscular disease, including transitional health care issues and increased funding for the NIH. H.R. 209/S. 139, Expanding Access to Clinical Trials Act of 2015 H.R. 6, 21st Century Cures and Innovation for Healthier Americans initiatives H.R. 1516/S. 1013, Ensuring Access to Quality Complex Rehabilitation Technology Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAC COALITION (INFORMAL COALITION) via KING & SPALDING LLP
2015 · second_quarter · Q2
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including the Audit and Appeal Fairness, Integrity, and Reforms in Medicare (AFIRM) Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2015 · second_quarter · Q2
Support of H.R. 1178/S. 1466, the Ensuring Equal Access to Treatments Act of 2015; advocacy in support of Medicare coverage for outpatient cancer drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2015 · second_quarter · Q2
Medicare Secondary Payer issues, H.R. 1063, S.1718, and H.R. 1845 (112th Congress) implementation, including H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RAC COALITION (INFORMAL COALITION) via KING & SPALDING LLP
2015 · first_quarter · Q1
Medicare Recovery Audit Contractor (RAC) program and RAC reform proposals including H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015 and H.R. 1021, Protecting the Integrity of Medicare Act of 2015
Filing targets: HOUSE OF REPRESENTATIVES, SENATE